Sanofi, GSK: COVID-19 Vaccine Candidate Selected By U.S. Government’s Operation Warp Speed

(RTTNews) - GlaxoSmithKline plc (GSK.L, GSK) and Sanofi (SNYNF, SNY) announced they were selected by U.S. government's Operation Warp Speed to supply with 100 million doses of COVID-19 recombinant protein-based vaccine. The U.S. government will provide up to $2.1 billion for development including clinical trials, manufacturing, scale-up and... To keep reading about Sanofi, GSK: COVID-19 Vaccine Candidate Selected By U.S. Government’s Operation Warp Speed, Click on the link. Seoul, Korea
http://dlvr.it/Rcl8CB

Comments

Popular posts from this blog

New Philadelphia Digital Agency Makes Its Public Debut

US intel chief rebukes lawmakers over 'pandemic' of leaks

New Data Suggest ExoFlo is Poised for a Quantum Leap in the Fight Against COVID-19